Denali Therapeutics Inc.

DNLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G May 15, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
SCHEDULE 13G/A May 6, 2026
3/A Apr 21, 2026 FORM 3/A
DEFA14A Apr 21, 2026 DEFA14A ADDITIONAL MATERIALS
ARS Apr 21, 2026 ARS
DEF 14A Apr 21, 2026 DEF 14A
3 Apr 20, 2026 FORM 3
8-K Apr 3, 2026 8-K
8-K Mar 31, 2026 8-K
SCHEDULE 13G/A Mar 26, 2026
8-K Mar 25, 2026 8-K
10-K Feb 26, 2026 10-K
S-8 Feb 26, 2026 S-8
8-K Feb 26, 2026 8-K
144 Feb 5, 2026
144 Feb 4, 2026
144 Feb 3, 2026
4 Jan 8, 2026 FORM 4
4 Jan 8, 2026 FORM 4
144 Jan 6, 2026
144 Jan 6, 2026
144 Jan 6, 2026
8-K Jan 6, 2026 8-K
← Newer Page 2 of 32 · 787 filings Older →